BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 16088277)

  • 1. Pleural fluid parameters identifying complicated parapneumonic effusions.
    Jiménez Castro D; Díaz Nuevo G; Sueiro A; Muriel A; Pérez-Rodríguez E; Light RW
    Respiration; 2005; 72(4):357-64. PubMed ID: 16088277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multilevel and continuous pleural fluid pH likelihood ratios for draining parapneumonic effusions.
    Heffner JE; Heffner JN; Brown LK
    Respiration; 2005; 72(4):351-6. PubMed ID: 16088276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleural fluid chemical analysis in parapneumonic effusions. A meta-analysis.
    Heffner JE; Brown LK; Barbieri C; DeLeo JM
    Am J Respir Crit Care Med; 1995 Jun; 151(6):1700-8. PubMed ID: 7767510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parapneumonic effusions and empyema.
    Light RW
    Clin Chest Med; 1985 Mar; 6(1):55-62. PubMed ID: 3847302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions.
    Porcel JM; Bielsa S; Esquerda A; Ruiz-González A; Falguera M
    Eur J Intern Med; 2012 Jul; 23(5):447-50. PubMed ID: 22726374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.
    Porcel JM; Galindo C; Esquerda A; Trujillano J; Ruiz-González A; Falguera M; Vives M
    Respirology; 2008 Jan; 13(1):58-62. PubMed ID: 18197912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of the British Thoracic Society and the American College of Chest Physicians guidelines in predicting pleural drainage of non-purulent parapneumonic effusions.
    Manuel Porcel J; Vives M; Esquerda A; Ruiz A
    Respir Med; 2006 May; 100(5):933-7. PubMed ID: 16253494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions.
    Maskell NA; Gleeson FV; Darby M; Davies RJ
    Chest; 2004 Dec; 126(6):2022-4. PubMed ID: 15596709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pleural fluid tests to identify complicated parapneumonic effusions.
    Porcel JM
    Curr Opin Pulm Med; 2010 Jul; 16(4):357-61. PubMed ID: 20224408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pleural fluid pH in parapneumonic pleural effusions: drawing the line.
    Kalomenidis I; Bouros D
    Respiration; 2005; 72(4):345-6. PubMed ID: 16088273
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment indication with endothoracic drainage tube in parapneumonic effusions by partial pressure of carbon dioxide measurement in pleural fluid].
    Santotoribio JD; Delgado-Pecellín C; León-Justel A; Guerrero JM
    Med Clin (Barc); 2008 Jun; 131(4):130-3. PubMed ID: 18601824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.
    Arnold DT; Hamilton FW; Elvers KT; Frankland SW; Zahan-Evans N; Patole S; Medford A; Bhatnagar R; Maskell NA
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1545-1553. PubMed ID: 32069085
    [No Abstract]   [Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha in pleural fluid: a marker of complicated parapneumonic effusions.
    Porcel JM; Vives M; Esquerda A
    Chest; 2004 Jan; 125(1):160-4. PubMed ID: 14718436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleural effusions caused by infection.
    Varkey B
    Postgrad Med; 1986 Oct; 80(5):213-6, 219, 222-3. PubMed ID: 3763525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Using of fibrinolytics in the treatment of complicated parapneumonic effusion and empyema in children].
    Uyan AP; Ozyürek H; Yilmaz E
    Tuberk Toraks; 2003; 51(3):320-4. PubMed ID: 15143413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
    Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
    Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pentraxin-3: A novel biomarker for discriminating parapneumonic from other exudative effusions.
    Ozsu S; Abul Y; Mentese A; Bektas H; Uzun A; Ozlu T; Porcel JM
    Respirology; 2013 May; 18(4):657-62. PubMed ID: 23286371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions.
    Heffner JE; Heffner JN; Brown LK
    Chest; 2003 Jun; 123(6):1887-94. PubMed ID: 12796164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between parapneumonic effusion and pericardial effusion in a pediatric cohort.
    Roberts JE; Bezack BJ; Winger DI; Pollack S; Shah RA; Cataletto M; Katz DS; Montoya-Iraheta C; Schroeder SA; Quintos-Alagheband ML
    Pediatrics; 2008 Dec; 122(6):e1231-5. PubMed ID: 18984649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of biochemical tests in the diagnosis of exudative pleural effusions.
    Ernam D; Atalay F; Hasanoglu HC; Kaplan O
    Clin Biochem; 2005 Jan; 38(1):19-23. PubMed ID: 15607312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.